Nisha Acharya, M.D.

Ophthalmologist

Conditions & Treatments

More about Nisha Acharya

Education

UCSF School of Medicine 2000

Residencies

Massachusetts Eye & Ear Infirmary, Ophthalmology 2004

Selected Research and Publications

1. Ray KJ, Prajna L, Srinivasan M, Geetha M, Karpagam R, Glidden D, Oldenburg CE, Sun CQ, McLeod SD, Acharya NR, Lietman TM. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmol. 2013 Mar 1; 131(3):310-3.
2. Oldenburg CE, Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Mascarenhas J, Nardone N, Ray KJ, Glidden DV, Acharya NR, Lietman TM. Moxifloxacin Susceptibility Mediates the Relationship between Causative Organism and Clinical Outcome in Bacterial Keratitis. Invest Ophthalmol Vis Sci. 2013; 54(2):1522-6.
3. Borkar DS, Fleiszig SM, Leong C, Lalitha P, Srinivasan M, Ghanekar AA, Tam C, Li WY, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Association Between Cytotoxic and Invasive Pseudomonas aeruginosa and Clinical Outcomes in Bacterial Keratitis. JAMA Ophthalmol. 2013 Feb 1; 131(2):147-53.
4. McClintic SM, Srinivasan M, Mascarenhas J, Greninger DA, Acharya NR, Lietman TM, Keenan JD. Improvement in corneal scarring following bacterial keratitis. Eye (Lond). 2013 Mar; 27(3):443-6.
5. See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Prior elicitation and bayesian analysis of the steroids for corneal ulcers trial. Ophthalmic Epidemiol. 2012 Dec; 19(6):407-13.
6. Gonzales JA, Levison AL, Stewart JM, Acharya NR, Margolis TP. Retinal necrosis following varicella-zoster vaccination. Arch Ophthalmol. 2012 Oct 1; 130(10):1355-6.
7. Lin CC, Lalitha P, Srinivasan M, Prajna NV, McLeod SD, Acharya NR, Lietman TM, Porco TC. Seasonal trends of microbial keratitis in South India. Cornea. 2012 Oct; 31(10):1123-7.
8. Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol. 2012 Dec; 154(6):934-939.e1.
9. Prajna VN, Lalitha PS, Mascarenhas J, Krishnan T, Srinivasan M, Vaitilingam CM, Oldenburg CE, Sy A, Keenan JD, Porco TC, Acharya NR, Lietman TM. Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial. Br J Ophthalmol. 2012 Nov; 96(11):1440-1.
10. Yoder JS, Verani J, Heidman N, Hoppe-Bauer J, Alfonso EC, Miller D, Jones DB, Bruckner D, Langston R, Jeng BH, Joslin CE, Tu E, Colby K, Vetter E, Ritterband D, Mathers W, Kowalski RP, Acharya NR, Limaye AP, Leiter C, Roy S, Lorick S, Roberts J, Beach MJ. Acanthamoeba keratitis: the persistence of cases following a multistate outbreak. Ophthalmic Epidemiol. 2012 Aug; 19(4):221-5.
11. Sy A, McLeod SD, Cohen EJ, Margolis TP, Mannis MJ, Lietman TM, Acharya NR. Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea. 2012 Jul; 31(7):786-90.
12. Mascarenhas J, Srinivasan M, Chen M, Rajaraman R, Ravindran M, Lalitha P, Oldenburg CE, Ray KJ, Glidden DV, Costanza S, Lietman TM, Acharya NR. Differentiation of etiologic agents of bacterial keratitis from presentation characteristics. Int Ophthalmol. 2012 Dec; 32(6):531-8.
13. Prajna NV, Krishnan T, Mascarenhas J, Srinivasan M, Oldenburg CE, Toutain-Kidd CM, Sy A, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Porco TC. Predictors of outcome in fungal keratitis. Eye (Lond). 2012 Sep; 26(9):1226-31.
14. Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, Vaitilingam CM, McLeod SD, Zegans ME, Porco TC, Acharya NR, Lietman TM. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea. 2012 Jun; 31(6):662-7.
15. Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, Kumar JA, Mascarenhas J, Margolis TP, Whitcher JP, Jeng BH, Keenan JD, Chan MF, McLeod SD, Acharya NR. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Invest Ophthalmol Vis Sci. 2012 Apr; 53(4):1787-91.
16. Lalitha P, Lin CC, Srinivasan M, Mascarenhas J, Prajna NV, Keenan JD, McLeod SD, Acharya NR, Lietman TM, Porco TC. Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics. Ophthalmic Epidemiol. 2012 Apr; 19(2):111-5.
17. Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb; 20(1):18-26.
18. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, Oldenburg CE, Ray KJ, Glidden D, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci. 2012 Jan; 53(1):267-72.
19. Tranos PG, Moore A, Pavesio C, Acharya NR, Johnson MW. Diagnostic and therapeutic challenges. Retina. 2012 Jan; 32(1):191-6.
20. Oldenburg CE, Acharya NR, Tu EY, Zegans ME, Mannis MJ, Gaynor BD, Whitcher JP, Lietman TM, Keenan JD. Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea. 2011 Dec; 30(12):1363-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.